Archangels — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
1nhaler1nhaler.comNov 2023
1nhaler develops a single-dose dry powder inhaler made mostly from cardboard, designed to be low-cost, portable, propellant-free and low in carbon impact for delivering inhalable medicines.
HealthtechMedical DevicesNew Materials
Helen Muirhead(Chief Scientific Officer)Lars Larsson(Chief Medical Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.